Efficacy and Safety of TAK-653 in Treatment-Resistant Depression

NCT03312894 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Treatment-Resistant Depression

Interventions

DRUG: TAK-653
DRUG: Placebo

Sponsor

Millennium Pharmaceuticals, Inc.